Partner with Twinome

Medication intelligence belongs wherever decisions happen.

Integrate the Passport, give people a reason to return, and turn medication moments into measurable value—without asking anyone to give up control of their information.

Find your ecosystem
Clinician and patient reviewing medication information together

Built for shared value

A connection should make your product better—not just add another data feed.

Every partnership follows the same three movements. Connect an audience or workflow to a patient-controlled Passport. Give people a recurring reason to engage. Then let useful actions produce outcomes you can measure.

01

Integrate

A scoped permission flow and an embedded Passport view.

02

Engage

Medication moments recur—each one a reason to return.

03

Create value

Consented outcomes you can actually measure.

One graph. Four ecosystems.

Start from the advantage you already have.

Choose the ecosystem closest to your organization to see how an integration takes shape, what value it is designed to create, and what we would need from you.

Consumer health and wearables

Give everyday signals somewhere useful to go.

Sleep, activity, symptoms and physiology already live in your product. A permissioned Passport turns those signals into medication context a person can act on and carry into care.

How the integration takes shape

  1. A Passport inside your app

    The person creates or connects a Twinome Passport from your product, with an embedded view designed to feel native.

  2. Permissioned signal exchange

    The signals the person approves flow in with their source and date attached. Nothing moves without an explicit, revocable permission.

  3. Context returns to your surface

    Explainable medication context—what changed and why it may matter—renders back inside your experience.

Integrate

One connection, not a data project

Start with a scoped permission flow and a single embedded Passport view rather than a multi-quarter integration.

Engage

A high-frequency reason to return

Medication moments recur weekly. Each one is a natural reason for a person to come back and check what their signals now mean.

Create value

New permissioned service pathways

With consent, a person can move from insight to a next step—testing, a care conversation or a research opportunity.

What we would ask of you

  • A permissioned way for a person to connect the signals they already share with you
  • Room in your product for an embedded Passport view
  • A named product owner and a defined pilot cohort
  • A pilot window measured in weeks, not quarters
Start with consumer health + wearables

Consent stays visible

Useful context should never outrun permission.

Permission

The person chooses what can move and for what purpose.

Provenance

Every material signal keeps its origin, date and verification state.

Decision

Only relevant context reaches the medication or research moment.

Outcome

What happens next can return—with consent—to the longitudinal graph.

The public evidence

Medication decisions sit inside one of the largest and most complex parts of American life.

45.8%

of Americans used a prescription drug1

Share of the U.S. population reporting prescription-drug use in the prior 30 days in the 2015–2016 NHANES cycle.

CDC/NCHS Data Brief 334, 2019

13.5%

used five or more prescriptions2

Age-adjusted share of U.S. adults using five or more prescription drugs in the prior 30 days, 2017–March 2020.

CDC/NCHS FastStats, 2024

24.7%

used three or more prescriptions3

Age-adjusted share of U.S. adults using three or more prescription drugs in the prior 30 days, 2017–March 2020.

CDC/NCHS FastStats, 2024
  1. 1. CDC/NCHS Data Brief 334 (2019). Share of the U.S. population reporting prescription-drug use in the prior 30 days in the 2015–2016 NHANES cycle.
  2. 2. CDC/NCHS FastStats (2024). Age-adjusted share of U.S. adults using five or more prescription drugs in the prior 30 days, 2017–March 2020.
  3. 3. CDC/NCHS FastStats (2024). Age-adjusted share of U.S. adults using three or more prescription drugs in the prior 30 days, 2017–March 2020.
  4. 4. CMS National Health Expenditure (2024). National health expenditures in 2024, equal to $15,474 per person and 18.0% of GDP.

Build with Twinome

Bring the audience, the workflow or the data connection.

Consumer health, payers, employers, care, pharmacy, data and research organizations can each begin from their own advantage. Tell us what success should look like—our team reviews every submission and follows up where there is a strong fit.

Start the conversation

Channel partnerships

Bring medication intelligence to where people already make decisions.

Tell us where your organization fits and what you want to build. The Twinome team reviews every submission.

Do not include patient information or protected health information.